1. Home
  2. SWBI vs RAPP Comparison

SWBI vs RAPP Comparison

Compare SWBI & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith & Wesson Brands Inc.

SWBI

Smith & Wesson Brands Inc.

HOLD

Current Price

$10.79

Market Cap

453.6M

Sector

Industrials

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$30.34

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWBI
RAPP
Founded
1852
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
453.6M
1.2B
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
SWBI
RAPP
Price
$10.79
$30.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$11.00
$47.80
AVG Volume (30 Days)
746.2K
361.1K
Earning Date
12-04-2025
11-06-2025
Dividend Yield
4.80%
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$466,396,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.56
N/A
P/E Ratio
$51.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.73
$6.43
52 Week High
$11.50
$42.27

Technical Indicators

Market Signals
Indicator
SWBI
RAPP
Relative Strength Index (RSI) 69.32 62.22
Support Level $10.58 $27.81
Resistance Level $11.23 $31.00
Average True Range (ATR) 0.38 1.84
MACD 0.28 0.11
Stochastic Oscillator 77.64 83.09

Price Performance

Historical Comparison
SWBI
RAPP

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: